跳至主要内容
临床试验/ACTRN12608000562370
ACTRN12608000562370已完成1 期

Double-blind randomised placebo cross-over trial of exogenous glucagon-like peptide-1 to establish the effect on glucose metabolism and gastric emptying during gastric feeding in critically ill patients

Royal Adelaide Hospital Intensive Care Unit0 个研究点目标入组 25 人开始时间: 2008年11月7日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
25

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
17 Years 至 90 Years(—)
性别
All

入选标准

  • critically ill patients and mechanically ventilated suitable for, or receiving, enteral nutrition and likely to stay ventilated for at least 48 hours.

排除标准

  • Pregnancy, Contraindication to enteral nutrient administration, Previous surgery on the oesophagus, stomach or duodenum, Any gastrointestinal surgery on this hospital admission and History of diabetes mellitus

研究者

发起方
Royal Adelaide Hospital Intensive Care Unit

相似试验